Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

CJ-15314: a novel JAK1 inhibitor for the treatment of rheumatoid arthritis

Nov. 19, 2019

Results presented from proof-of-concept phase I study of cenerimod

Nov. 18, 2019

I-Mab obtains Chinese IND clearance for phase I trials of TJM-2 in rheumatoid arthritis

Nov. 15, 2019

New phase II trial evaluates KN-019 in rheumatoid arthritis

Nov. 14, 2019

KINE-101, a novel synthetic peptide for rheumatoid arthritis

Nov. 14, 2019

RNA controls muscle stem cells

Nov. 13, 2019

NKTR-358 safe and well tolerated in first-in-human study

Nov. 11, 2019

Antisense therapy with antagomiR-23b shows promise for the treatment of DM1

Nov. 8, 2019

Voclosporin DDI study demonstrates no clinically significant interaction with MMF

Nov. 8, 2019

Rinvoq meets primary and all ranked secondary endpoints in phase III SELECT-PsA 2 study

Nov. 4, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...